En esta página
SRRK Scholar Rock Holding Corporation - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 6, 2026
$46,81
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$27,07mínimo 52 semanas
$61,76máximo 52 semanas
Capitalización Bursátil (MRQ)
$5.69B
P/E (TTM)
-14.1
BPA (TTM)
$-3.31
Ingresos (TTM)
$0
tus insignias
Rango 52S
$27–$62
Calificación del Analista
BUY
Precio Objetivo
$70
P/E
-14.1
ROE
-167.8%
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
SRRK Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$46.81
Capitalización Bursátil (MRQ)
$5.69B
P/E (TTM)
-14.1
BPA (TTM)
$-3.31
Ingresos (TTM)
$0
ROE (TTM)
-167.8%
Deuda/Capital (MRQ)
0.8
Rango 52S
$27–$62
SRRK Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$02018-12-31 → 2025-12-31
BPA$-3.292020-12-31 → 2025-12-31
Flujo de caja libre$-301M2018-12-31 → 2025-12-31
Margen neto·2019-12-31 → 2022-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | SRRK | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | -14.1promedio 5A ≈-10.3 | ≈-10.3 | · | · | |
| P/C (MRQ) | 22.4promedio 5A ≈8.7 | ≈8.7 | 11.6 | Sobrevalorado | |
| EV / EBITDA | -12.5promedio 5A ≈-8.0 | ≈-8.0 | · | · | |
| Precio / FCF (TTM) | -19.2promedio 5A ≈-11.2 | ≈-11.2 | · | · | |
| Precio / Flujo de Caja (TTM) | -19.2promedio 5A ≈-11.3 | ≈-11.3 | · | · | |
| EV / FCF (TTM) | -18.2promedio 5A ≈-9.6 | ≈-9.6 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 20.7promedio 5A ≈8.7 | ≈8.7 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | SRRK | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| ROA (TTM) | -94.6%promedio 5A ≈-55.4% | ≈-55.4% | -23.8% | Débil | |
| ROE (TTM) | -167.8%promedio 5A ≈-94.8% | ≈-94.8% | -34.6% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | SRRK | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Deuda / Patrimonio (MRQ) | 0.8promedio 5A ≈0.2 | ≈0.2 | 0.5 | Deuda alta | |
| Ratio corriente (MRQ) | 7.0promedio 5A ≈7.7 | ≈7.7 | 7.3 | Baja liquidez | |
| Quick Ratio (Ratio Rápido) | 6.6promedio 5A ≈7.4 | ≈7.4 | 3.1 | Liquidez sólida | |
| Deuda a Largo Plazo / Patrimonio (MRQ) | 0.8promedio 5A ≈0.2 | ≈0.2 | 0.5 | Deuda alta |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | SRRK | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.0promedio 5A ≈0.1 | ≈0.1 | 0.0 | Débil | |
| Revenue / Employee (Ingresos / Empleado) | ≈$0.00 | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-7.6%
Próximo informe
Nov 12, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 12, 2026 | $-0.84 | $-0.86 | 2.0% |
| 31 de marzo de 2026 | May 12, 2026 | $-0.83 | $-0.82 | -1.6% |
| 31 de diciembre de 2025 | $-0.88 | $-0.91 | 3.1% | |
| 30 de septiembre de 2025 | $-0.90 | $-0.86 | -5.2% | |
| 30 de junio de 2025 | $-0.98 | $-0.68 | -44.6% | |
| 31 de marzo de 2025 | $-0.67 | $-0.67 | 0.64% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | · | · | $33M | $19M | $15M | $20M | $0 | |
| R&D Expense | $208M | $185M | $122M | $124M | $108M | $74M | $54M | $36M | |
| SG&A Expense | $176M | $68M | $49M | $43M | $40M | $28M | $21M | $14M | |
| Operating Expenses | $385M | $252M | $171M | $168M | $149M | $102M | $75M | $51M | |
| Operating Income | $-385M | $-252M | $-171M | $-134M | $-130M | $-87M | $-55M | $-51M | |
| Other Non-op | $-301.0K | $-85.0K | $6M | $-132.0K | $-2M | $395.0K | $4M | $1M | |
| Net Income | $-378M | $-246M | $-166M | $-135M | $-132M | $-86M | $-51M | $-49M | |
| EPS (Basic) | $-3.29 | $-2.47 | $-1.99 | $-2.26 | $-3.59 | $-2.81 | · | · | |
| EPS (Diluted) | $-3.29 | $-2.47 | $-1.99 | $-2.26 | $-3.59 | $-2.81 | · | · | |
| Shares (Basic) | 114,701,154 | 99,838,102 | 83,347,086 | 59,611,656 | 36,711,833 | 30,734,109 | · | · | |
| Shares (Diluted) | 114,701,154 | 99,838,102 | 83,347,086 | 59,611,656 | 36,711,833 | 30,734,109 | · | · | |
| EBITDA | $-385M | $-252M | $-171M | $-134M | $-130M | $-87M | $-55M | $-51M |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $324M | $178M | $102M | $103M | $213M | $160M | $36M | $115M | |
| Short-term Investments | $44M | $259M | $178M | $212M | $40M | $181M | $121M | $61M | |
| Receivables | · | · | · | · | · | · | $25M | · | |
| Prepaid Expense | $18M | $14M | $8M | $13M | $12M | $3M | $3M | $2M | |
| Current Assets | $385M | $451M | $288M | $328M | $265M | $344M | $185M | $178M | |
| PP&E (Net) | $2M | $3M | $5M | $7M | $10M | $8M | $4M | $3M | |
| PP&E (Gross) | $17M | $16M | $16M | $18M | $17M | $13M | $8M | $6M | |
| Accum. Depreciation | $15M | $13M | $11M | $10M | $7M | $5M | $4M | $2M | |
| Other Non-current Assets | $3M | $3M | $4M | $2M | $2M | $1M | $98.0K | · | |
| Total Assets | $404M | $475M | $311M | $358M | $304M | $388M | $196M | $181M | |
| Accounts Payable | $10M | $10M | $3M | $4M | $4M | $3M | $1M | $3M | |
| Accrued Liabilities | $40M | $31M | $20M | $24M | $17M | $15M | $10M | $7M | |
| Short-term Debt | · | · | $1M | · | $2M | · | · | · | |
| Current Liabilities | $55M | $47M | $33M | $36M | $64M | $43M | $33M | $31M | |
| Capital Leases | $4M | $9M | $4M | $12M | $20M | $27M | $4M | · | |
| Other Non-current Liabilities | · | · | · | · | · | $5.0K | $9.0K | · | |
| Total Liabilities | $159M | $106M | $86M | $98M | $132M | $128M | $83M | $75M | |
| Long-term Debt | · | · | $51M | $51M | $52M | $26M | · | · | |
| Total Debt | $100M | $50M | $50M | $50M | $50M | $25M | · | · | |
| Common Stock | $108.0K | $94.0K | $76.0K | $52.0K | $35.0K | $34.0K | $30.0K | $26.0K | |
| Paid-in Capital | $1.55B | $1.29B | $901M | $772M | $548M | $505M | $271M | $213M | |
| Retained Earnings | $-1.30B | $-923M | $-676M | $-511M | $-376M | $-244M | $-158M | $-107M | |
| AOCI | $94.0K | $160.0K | $92.0K | $-884.0K | $-35.0K | $-2.0K | $37.0K | $-8.0K | |
| Stockholders' Equity | $245M | $369M | $225M | $260M | $172M | $261M | $113M | $107M | |
| Liabilities + Equity | $404M | $475M | $311M | $358M | $304M | $388M | $196M | $181M | |
| Shares Outstanding | 108,461,354 | 93,823,678 | 75,979,495 | 51,672,579 | 35,209,099 | 34,152,470 | 29,792,922 | 26,217,701 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $3M | $3M | $3M | $1M | $1M | $800.0K | |
| Stock-based Comp | $76M | $37M | $27M | $28M | $23M | $11M | $8M | $5M | |
| Operating Cash Flow | $-300M | $-201M | $-145M | $-133M | $-127M | $-60M | $-63M | $25M | |
| CapEx | $602.0K | $98.0K | $71.0K | $1M | $5M | $4M | $3M | $1M | |
| Investing Cash Flow | $219M | $-76M | $41M | $-172M | $134M | $-63M | $-62M | $-60M | |
| Debt Issued | $25M | · | · | · | · | · | · | · | |
| Net Debt Issued | $-852.0K | · | · | · | · | · | · | · | |
| Stock Issued | $92M | $324M | $98M | $195M | $13M | $216M | $48M | $95M | |
| Net Stock Activity | $92M | $324M | $98M | $195M | $13M | $216M | $48M | $17M | |
| Financing Cash Flow | $228M | $353M | $103M | $195M | $45M | $248M | $49M | $94M | |
| Net Change in Cash | · | $76M | $-2M | $-110M | $52M | $124M | $-76M | $59M | |
| Taxes Paid | $46.0K | · | · | · | · | · | · | · | |
| Free Cash Flow | $-301M | $-201M | $-145M | $-134M | $-132M | $-64M | $-66M | $23M |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -404.8% | -690.5% | -564.0% | -266.2% | · | |
| Net Margin | · | · | · | -405.2% | -700.5% | -561.5% | -248.9% | · | |
| EBITDA Margin | · | · | · | -404.8% | -690.5% | -564.0% | -266.2% | · | |
| ROA | -86.0% | -62.7% | -49.5% | -40.6% | -38.0% | -29.6% | -27.0% | -40.6% | |
| ROE | -157.9% | -110.0% | -84.4% | -48.6% | -73.4% | -53.4% | -43.5% | -47.2% |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.9 | 9.6 | 8.8 | 9.0 | 4.1 | 8.1 | 5.6 | 5.7 | |
| Quick Ratio | 6.6 | 9.3 | 8.6 | 8.7 | 3.9 | 8.0 | 5.6 | 5.6 | |
| Debt / Equity | 0.4 | 0.1 | 0.2 | 0.2 | 0.3 | 0.1 | · | · | |
| LT Debt / Equity | 0.4 | 0.1 | 0.2 | 0.2 | 0.3 | 0.1 | · | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | 1.6 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.26 | $3.93 | $2.96 | $5.04 | $4.89 | $7.64 | $3.79 | $4.07 | |
| Revenue / Share | $0.00 | · | · | $0.56 | $0.51 | · | · | · | |
| Cash Flow / Share | $-2.62 | $-2.01 | $-1.74 | $-2.23 | $-3.45 | · | · | · | |
| Cash / Share | $2.98 | $1.90 | $1.34 | $2.00 | $6.04 | $4.70 | $1.22 | $4.39 | |
| EPS (TTM) | $-3.29 | $-2.47 | $-1.99 | $-2.26 | $-3.59 | $-2.81 | · | · |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | 76.4% | 22.2% | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $48M | $48M | $33M | $19M | $15M | $20M | $0 | |
| Net Income TTM | $-378M | $-246M | $-166M | $-135M | $-132M | $-86M | $-51M | $-49M | |
| Market Cap | $4.78B | $4.06B | $1.43B | $468M | $875M | $1.66B | $393M | $602M | |
| Enterprise Value | $4.51B | $3.67B | $1.20B | $202M | $672M | $1.34B | · | · | |
| P/E | -13.4 | -17.5 | -9.4 | -4.0 | -6.9 | -17.3 | · | · | |
| P/S | · | 84.6 | 29.8 | 14.1 | 46.5 | 107.6 | 19.2 | · | |
| P/B | 19.5 | 11.0 | 6.3 | 1.8 | 5.1 | 6.4 | 3.5 | 5.6 | |
| P / Tangible Book | 19.5 | 11.0 | 6.3 | 1.8 | 5.1 | 6.4 | · | · | |
| P / Cash Flow | -15.9 | -20.2 | -9.8 | -3.5 | -6.9 | -27.5 | -6.2 | 24.5 | |
| P / FCF | -15.9 | -20.2 | -9.8 | -3.5 | -6.6 | -25.8 | -5.9 | 26.1 | |
| EV / EBITDA | -11.7 | -14.6 | -7.0 | -1.5 | -5.2 | -15.4 | · | · | |
| EV / FCF | -15.0 | -18.2 | -8.2 | -1.5 | -5.1 | -20.8 | · | · | |
| EV / Revenue | · | 76.5 | 25.0 | 6.1 | 35.7 | 87.1 | · | · | |
| Earnings Yield | -7.5% | -5.7% | -10.6% | -25.0% | -14.4% | -5.8% | · | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| R&D Expense | $58M | $52M | $47M | $50M | $62M | $49M | $50M | $49M | $42M | $43M | $35M | $30M | $27M | $30M | $30M | $33M | |
| SG&A Expense | $51M | $50M | $45M | $53M | $50M | $28M | $19M | $16M | $17M | $15M | $13M | $13M | $12M | $11M | $11M | $10M | |
| Operating Expenses | $109M | $102M | $92M | $104M | $112M | $77M | $69M | $65M | $59M | $58M | $48M | $44M | $39M | $41M | $40M | $44M | |
| Operating Income | $-109M | $-102M | $-92M | $-104M | $-112M | $-77M | $-69M | $-65M | $-59M | $-58M | $-48M | $-44M | $-39M | $-41M | $-40M | $-44M | |
| Other Non-op | $-570.0K | $-790.0K | $-2M | $-69.0K | $-127.0K | $-44.0K | $-2M | $-38.0K | $-14.0K | $2M | $2M | $1M | $1M | $1M | $1M | $565.0K | |
| Net Income | $-110M | $-106M | $-91M | $-102M | $-110M | $-75M | $-66M | $-64M | $-59M | $-57M | $-46M | $-42M | $-38M | $-39M | $-39M | $-43M | |
| EPS (Basic) | $-0.84 | $-0.83 | $-0.74 | $-0.90 | $-0.98 | $-0.67 | $-0.62 | $-0.66 | $-0.60 | $-0.59 | $-0.50 | $-0.53 | $-0.47 | $-0.49 | $-0.44 | $-0.55 | |
| EPS (Diluted) | $-0.84 | $-0.83 | $-0.74 | $-0.90 | $-0.98 | $-0.67 | $-0.62 | $-0.66 | $-0.60 | $-0.59 | $-0.50 | $-0.53 | $-0.47 | $-0.49 | $-0.44 | $-0.55 | |
| Shares (Basic) | 130,612,734 | 127,277,144 | · | 113,729,850 | 112,703,014 | 111,838,272 | · | 97,050,637 | 96,813,116 | 95,892,601 | · | 80,606,438 | 80,117,983 | 79,610,059 | · | 79,336,161 | |
| Shares (Diluted) | 130,612,734 | 127,277,144 | · | 113,729,850 | 112,703,014 | 111,838,272 | · | 97,050,637 | 96,813,116 | 95,892,601 | · | 80,606,438 | 80,117,983 | 79,610,059 | · | 79,336,161 | |
| EBITDA | $-109M | $-102M | · | $-104M | $-112M | $-77M | · | $-65M | $-59M | $-58M | · | $-44M | $-39M | $-41M | · | $-44M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $437M | $431M | $324M | $287M | $153M | $138M | $178M | $76M | $93M | $92M | $102M | $68M | $108M | $151M | $103M | $133M | |
| Short-term Investments | $55M | $49M | $44M | $83M | $142M | $226M | $259M | $63M | $97M | $146M | $178M | $151M | $141M | $124M | $212M | $211M | |
| Prepaid Expense | $15M | $35M | $18M | $21M | $24M | $21M | $14M | $14M | $9M | $9M | $8M | $10M | $11M | $12M | $13M | $14M | |
| Current Assets | $507M | $515M | $385M | $391M | $319M | $385M | $451M | $153M | $199M | $247M | $288M | $228M | $260M | $287M | $328M | $358M | |
| PP&E (Net) | $1M | $1M | $2M | $2M | $2M | $3M | $3M | $3M | $4M | $4M | $5M | $5M | $6M | $7M | $7M | $8M | |
| PP&E (Gross) | · | · | $17M | · | · | · | $16M | · | · | · | $16M | · | · | · | $18M | · | |
| Accum. Depreciation | · | · | $15M | · | · | · | $13M | · | · | · | $11M | · | · | · | $10M | · | |
| Other Non-current Assets | $3M | $5M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $1M | $2M | $2M | $2M | $2M | |
| Total Assets | $524M | $535M | $404M | $412M | $340M | $408M | $475M | $179M | $227M | $267M | $311M | $251M | $285M | $315M | $358M | $390M | |
| Accounts Payable | $11M | $9M | $10M | $7M | $1M | $4M | $10M | $4M | $3M | $3M | $3M | $2M | $3M | $4M | $4M | $2M | |
| Accrued Liabilities | $55M | $44M | $40M | $50M | $44M | $28M | $31M | $29M | $22M | $21M | $20M | $17M | $14M | $15M | $24M | $23M | |
| Short-term Debt | · | · | · | · | · | · | · | · | $2M | $6M | $1M | · | · | · | · | $805.0K | |
| Current Liabilities | $72M | $60M | $55M | $62M | $50M | $38M | $47M | $39M | $33M | $38M | $33M | $27M | $24M | $26M | $36M | $34M | |
| Capital Leases | $1M | $3M | $4M | $5M | $7M | $8M | $9M | $10M | $12M | $2M | $4M | $6M | $8M | $10M | $12M | $14M | |
| Total Liabilities | $270M | $259M | $159M | $167M | $107M | $95M | $106M | $100M | $93M | $85M | $86M | $83M | $82M | $86M | $98M | $97M | |
| Total Debt | $196M | $197M | · | $100M | $50M | $50M | · | $50M | $50M | $50M | · | $50M | $50M | $50M | · | $51M | |
| Common Stock | $122.0K | $119.0K | $108.0K | $99.0K | $96.0K | $95.0K | $94.0K | $80.0K | $80.0K | $80.0K | $76.0K | $56.0K | $55.0K | $52.0K | $52.0K | $52.0K | |
| Paid-in Capital | $1.77B | $1.68B | $1.55B | $1.45B | $1.34B | $1.31B | $1.29B | $935M | $925M | $916M | $901M | $798M | $790M | $779M | $772M | $766M | |
| Retained Earnings | $-1.52B | $-1.41B | $-1.30B | $-1.21B | $-1.11B | $-997M | $-923M | $-856M | $-792M | $-733M | $-676M | $-630M | $-588M | $-550M | $-511M | $-471M | |
| AOCI | $1M | $690.0K | $94.0K | $117.0K | $58.0K | $129.0K | $160.0K | $128.0K | $-54.0K | $-50.0K | $92.0K | $-23.0K | $-63.0K | $-329.0K | $-884.0K | $-936.0K | |
| Stockholders' Equity | $254M | $276M | $245M | $245M | $233M | $312M | $369M | $79M | $134M | $183M | $225M | $168M | $203M | $229M | $260M | $293M | |
| Liabilities + Equity | $524M | $535M | $404M | $412M | $340M | $408M | $475M | $179M | $227M | $267M | $311M | $251M | $285M | $315M | $358M | $390M | |
| Shares Outstanding | 121,600,396 | 119,103,774 | 108,461,354 | 99,171,486 | 95,999,608 | 94,873,407 | 93,823,678 | 80,081,535 | 79,992,068 | 79,744,654 | 75,979,495 | 56,260,574 | 55,159,787 | 51,989,359 | 51,672,579 | 51,660,854 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $297.0K | $335.0K | $425.0K | $423.0K | $417.0K | $393.0K | $395.0K | $446.0K | $498.0K | $598.0K | $672.0K | $708.0K | $731.0K | $733.0K | $749.0K | $744.0K | |
| Stock-based Comp | $20M | $18M | $19M | $18M | $24M | $13M | $10M | $10M | $9M | $8M | $7M | $7M | $7M | $6M | $6M | $8M | |
| Operating Cash Flow | $-70M | $-82M | $-75M | $-69M | $-77M | $-79M | $-50M | $-52M | $-49M | $-50M | $-37M | $-32M | $-33M | $-43M | $-29M | $-26M | |
| CapEx | $1.0K | $68.0K | $32.0K | $84.0K | $215.0K | $271.0K | $22.0K | $31.0K | $22.0K | $23.0K | $0 | $0 | $41.0K | $30.0K | $117.0K | $27.0K | |
| Investing Cash Flow | $-6M | $-5M | $39M | $60M | $85M | $35M | $-195M | $35M | $51M | $33M | $-25M | $-8M | $-15M | $90M | $77.0K | $-146M | |
| Debt Issued | · | · | $0 | $0 | $1.0K | $25M | · | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | · | $-103M | · | · | · | $-853.0K | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $63M | $98M | $2.0K | $92M | · | · | · | · | · | · | $92M | $0 | $4M | $827.0K | $0 | $-455.0K | |
| Net Stock Activity | · | $98M | · | · | · | · | · | · | · | · | · | · | · | $827.0K | · | · | |
| Financing Cash Flow | $83M | $194M | $73M | $144M | $6M | $4M | $346M | $166.0K | $-33.0K | $7M | $97M | $280.0K | $5M | $1M | $-970.0K | $-451.0K | |
| Net Change in Cash | · | · | · | $135M | $15M | $-40M | · | $-17M | $1M | $-10M | $34M | $-40M | $-43M | $48M | $-30M | $-173M | |
| Free Cash Flow | · | $-82M | · | · | · | $-79M | · | · | · | $-50M | · | · | · | $-43M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -25.4% | -22.4% | · | -34.6% | -38.8% | -22.1% | · | -30.0% | -22.9% | -19.5% | · | -13.2% | -10.7% | -13.6% | · | -12.6% | |
| ROE | -45.1% | -35.9% | · | -63.1% | -60.0% | -30.2% | · | -52.2% | -34.8% | -27.6% | · | -18.4% | -14.3% | -19.7% | · | -18.0% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.0 | 8.6 | · | 6.3 | 6.3 | 10.3 | · | 3.9 | 6.0 | 6.6 | · | 8.5 | 10.7 | 11.0 | · | 10.6 | |
| Quick Ratio | 6.8 | 8.0 | · | 6.0 | 5.8 | 9.7 | · | 3.5 | 5.8 | 6.4 | · | 8.2 | 10.2 | 10.5 | · | 10.2 | |
| Debt / Equity | 0.8 | 0.7 | · | 0.4 | 0.2 | 0.2 | · | 0.6 | 0.4 | 0.3 | · | 0.3 | 0.2 | 0.2 | · | 0.2 | |
| LT Debt / Equity | 0.8 | 0.7 | · | 0.4 | 0.2 | 0.2 | · | 0.6 | 0.4 | 0.2 | · | 0.3 | 0.2 | 0.2 | · | 0.2 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.09 | $2.32 | · | $2.47 | $2.43 | $3.29 | · | $0.99 | $1.67 | $2.29 | · | $2.98 | $3.67 | $4.40 | · | $5.68 | |
| Revenue / Share | · | $0.00 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $-0.65 | · | · | · | $-0.70 | · | · | · | $-0.52 | · | · | · | $-0.54 | · | · | |
| Cash / Share | $3.59 | $3.61 | · | $2.89 | $1.59 | $1.45 | · | $0.95 | $1.17 | $1.15 | · | $1.20 | $1.96 | $2.91 | · | $2.58 | |
| EPS (TTM) | $-3.31 | $-3.45 | · | $-3.17 | $-2.93 | $-2.55 | · | $-2.35 | $-2.22 | $-2.09 | · | $-1.93 | $-1.95 | $-2.54 | · | $-2.79 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | · | · | · | $33M | $33M | · | $33M | $33M | $33M | · | $33M | $33M | $33M | · | $37M | |
| Net Income TTM | $-409M | $-409M | · | $-353M | $-316M | $-264M | · | $-226M | $-204M | $-183M | · | $-159M | $-160M | $-166M | · | $-131M | |
| Market Cap | $6.69B | $5.86B | · | $3.69B | $3.40B | $3.05B | · | $641M | $666M | $1.42B | · | $399M | $416M | $416M | · | $358M | |
| Enterprise Value | $6.39B | $5.57B | · | $3.42B | $3.16B | $2.74B | · | $552M | $526M | $1.23B | · | $231M | $217M | $190M | · | $65M | |
| P/E | -16.6 | -14.2 | · | -11.7 | -12.1 | -12.6 | · | -3.4 | -3.8 | -8.5 | · | -3.7 | -3.9 | -3.1 | · | -2.5 | |
| P/S | · | · | · | · | 102.4 | 91.9 | · | 19.3 | 20.1 | 42.7 | · | 12.0 | 12.5 | 12.5 | · | 9.6 | |
| P/B | 26.4 | 21.2 | · | 15.1 | 14.6 | 9.8 | · | 8.1 | 5.0 | 7.7 | · | 2.4 | 2.1 | 1.8 | · | 1.2 | |
| P / Tangible Book | 26.4 | 21.2 | · | 15.1 | 14.6 | 9.8 | · | 8.1 | 5.0 | 7.7 | · | 2.4 | 2.1 | 1.8 | · | 1.2 | |
| P / Cash Flow | · | -71.3 | · | · | · | -38.8 | · | · | · | -28.4 | · | · | · | -9.7 | · | · | |
| EV / Revenue | · | · | · | · | 95.1 | 82.4 | · | 16.6 | 15.8 | 37.0 | · | 7.0 | 6.5 | 5.7 | · | 1.7 | |
| Earnings Yield | -6.0% | -7.0% | · | -8.5% | -8.3% | -7.9% | · | -29.3% | -26.7% | -11.8% | · | -27.2% | -25.9% | -31.8% | · | -40.3% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $0 | · | · | $33M | $19M |
| Margen Operativo % | · | · | · | -404.8% | -690.5% |
| Beneficio neto | $-378M | $-246M | $-166M | $-135M | $-132M |
| EPS Diluido | $-3.29 | $-2.47 | $-1.99 | $-2.26 | $-3.59 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Deuda / Patrimonio | 0.4 | 0.1 | 0.2 | 0.2 | 0.3 |
| Ratio corriente | 6.9 | 9.6 | 8.8 | 9.0 | 4.1 |
| Ratio Rápido | 6.6 | 9.3 | 8.6 | 8.7 | 3.9 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-301M | $-201M | $-145M | $-134M | $-132M |
Propietarios institucionales (13F) 326 declarantes · $7.5B total · A fecha de 30 de septiembre de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
326
Valor en tenencia
$7.5B
Nuevas posiciones
54
Posiciones cerradas
22
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 54 (+4 vs trimestre anterior) | 22 (-12 vs trimestre anterior) | 130 (+17 vs trimestre anterior) | 83 (+3 vs trimestre anterior) | +2.9M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| FMR LLC | $989 738 234 | 17 995 241 | 13,22% | Acciones |
| Siren, L.L.C. | $526 625 715 | 9 575 013 | 7,03% | Acciones |
| BlackRock, Inc. | $522 174 620 | 9 494 084 | 6,97% | Acciones |
| SAMSARA BIOCAPITAL, LLC | $379 370 860 | 6 897 652 | 5,07% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $369 989 675 | 6 727 085 | 4,94% | Acciones |
| Orbis Allan Gray Ltd | $326 344 315 | 5 933 533 | 4,36% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $262 233 400 | 4 767 880 | 3,50% | Acciones |
| STATE STREET CORP | $260 077 455 | 4 728 681 | 3,47% | Acciones |
| Redmile Group, LLC | $237 110 060 | 4 311 092 | 3,17% | Acciones |
| VANGUARD GROUP INC | $228 860 234 | 5 195 465 | 3,06% | Acciones |
| NORGES BANK | $152 345 050 | 2 769 910 | 2,03% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $151 488 554 | 2 753 787 | 2,02% | Acciones |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $143 393 380 | 2 607 348 | 1,92% | Acciones |
| Bellevue Group AG | $134 725 085 | 2 449 547 | 1,80% | Acciones |
| JENNISON ASSOCIATES LLC | $129 722 285 | 2 358 587 | 1,73% | Acciones |
| Hood River Capital Management LLC | $122 363 340 | 2 224 788 | 1,63% | Acciones |
| Driehaus Capital Management LLC | $121 308 990 | 2 205 618 | 1,62% | Acciones |
| EVENTIDE ASSET MANAGEMENT, LLC | $116 126 838 | 2 111 410 | 1,55% | Acciones |
| JANUS HENDERSON GROUP PLC | $109 890 973 | 2 236 837 | 1,47% | Acciones |
| Polar Capital Holdings Plc | $103 321 900 | 1 878 580 | 1,38% | Acciones |
| Holocene Advisors, LP | $96 578 790 | 1 755 978 | 1,29% | Acciones |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $95 227 110 | 1 731 402 | 1,27% | Acciones |
| MORGAN STANLEY | $84 632 717 | 1 538 776 | 1,13% | Acciones |
| Woodline Partners LP | $82 525 850 | 1 500 470 | 1,10% | Acciones |
| GOLDMAN SACHS GROUP INC | $77 631 235 | 1 411 477 | 1,04% | Acciones |
| Capital World Investors | $63 822 495 | 1 160 409 | 0,85% | Acciones |
| Clearbridge Investments, LLC | $58 287 699 | 1 059 776 | 0,78% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $56 504 635 | 1 027 357 | 0,75% | Acciones |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $53 891 475 | 979 845 | 0,72% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $53 635 955 | 975 197 | 0,72% | Acciones |
| NORTHERN TRUST CORP | $53 601 680 | 974 576 | 0,72% | Acciones |
| BANK OF AMERICA CORP /DE/ | $53 474 135 | 972 257 | 0,71% | Acciones |
| Pictet Asset Management Holding SA | $50 106 164 | 911 075 | 0,67% | Acciones |
| VOYA INVESTMENT MANAGEMENT LLC | $48 983 385 | 890 607 | 0,65% | Acciones |
| FRANKLIN RESOURCES INC | $48 329 930 | 878 726 | 0,65% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $47 535 730 | 864 286 | 0,63% | Acciones |
| Integral Health Asset Management, LLC | $41 250 000 | 750 000 | 0,55% | Acciones |
| FEDERATED HERMES, INC. | $40 398 215 | 734 513 | 0,54% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $40 154 565 | 730 083 | 0,54% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $39 463 160 | 717 512 | 0,53% | Acciones |
| Rock Springs Capital Management LP | $39 349 860 | 715 452 | 0,53% | Acciones |
| Casdin Capital, LLC | $36 575 000 | 665 000 | 0,49% | Acciones |
| Nuveen, LLC | $35 846 195 | 651 749 | 0,48% | Acciones |
| LOOMIS SAYLES & CO L P | $32 783 025 | 596 055 | 0,44% | Acciones |
| Ensign Peak Advisors, Inc | $31 847 860 | 579 052 | 0,43% | Acciones |
| Eagle Health Investments LP | $30 539 960 | 555 272 | 0,41% | Acciones |
| UBS Group AG | $28 114 350 | 511 170 | 0,38% | Acciones |
| Qube Research & Technologies Ltd | $25 505 150 | 463 730 | 0,34% | Acciones |
| Fisher Asset Management, LLC | $24 169 585 | 439 447 | 0,32% | Acciones |
| MARSHALL WACE, LLP | $23 677 500 | 430 500 | 0,32% | Acciones |
Activistas y propietarios del %+ 5 1 tenencia
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Samsara BioCapital, L.P., Samsara BioCapital GP, LLC, Samsara Opportunity Fund, L.P., Samsara Opportunity Fund GP, LLC, Srinivas Akkaraju ×4 presentaciones | 7 de octubre de 2025 | 7,20% | Enmienda | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 28 insiders · 19 directivos · 12 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| David Hallal | Chief Executive Officer | 21 de septiembre de 2026 G | 1 602 382 | 0 | 2 | $-3 970 701 |
| Jay T. Backstrom | CHIEF EXECUTIVE OFFICER | 10 de marzo de 2025 A | 425 561 | 0 | 0 | $0 |
| Nagesh K. Manhathappa | Interim CEO and President | 16 de junio de 2022 A | 480 491 | 0 | 0 | $0 |
| Stuart A Kingsley | President and CEO | 1 de febrero de 2021 A | 42 000 | 0 | 0 | $0 |
| Vikas Sinha | Chief Financial Officer | 16 de abril de 2026 S | 619 856 | 0 | 2 | $-1 231 462 |
| Edward H Myles | COO & CFO | 10 de marzo de 2025 M | 111 345 | 0 | 0 | $0 |
| Rhonda M. Chicko | Chief Financial Officer | 31 de enero de 2019 A | · | 0 | 0 | $0 |
| Akshay Vaishnaw | President of R&D | 16 de abril de 2026 S | 630 542 | 0 | 2 | $-1 479 737 |
| Keith Woods | Chief Operating Officer | 24 de septiembre de 2026 G | 572 021 | 0 | 2 | $-1 221 659 |
| Elan Ezickson | COO & Head of Corp.Development | 29 de mayo de 2018 A | · | 0 | 0 | $0 |
| Mo Qatanani | CHIEF SCIENTIFIC OFFICER | 23 de febrero de 2026 S | 98 445 | 0 | 9 | $-8 602 966 |
| Caryn Parlavecchio | CHRO | 17 de febrero de 2026 S | 169 087 | 0 | 2 | $-713 967 |
| Junlin Ho | GENERAL COUNSEL | 17 de febrero de 2026 S | 241 545 | 0 | 2 | $-802 309 |
| Jing L. Marantz | CHIEF MEDICAL OFFICER | 17 de febrero de 2026 S | 126 012 | 0 | 2 | $-451 320 |
| Tracey Sacco | Chief Commercial Officer | 25 de abril de 2025 M | 71 750 | 0 | 0 | $0 |
| Erin Moore | Interim PFO and PAO | 24 de marzo de 2025 M | 82 609 | 0 | 0 | $0 |
| Gregory John Carven | Chief Scientific Officer | 16 de junio de 2022 A | 128 208 | 0 | 0 | $0 |
| Yung H. Chyung | Chief Medical Officer | 14 de febrero de 2022 A | 258 496 | 0 | 0 | $0 |
| Alan J. Buckler | Chief Scientific Officer | 6 de febrero de 2020 A | · | 0 | 0 | $0 |
| Katie Peng | Consejero | 1 de julio de 2026 S | 34 301 | 0 | 5 | $-337 751 |
| Joshua Reed | Consejero | 1 de julio de 2026 S | 19 518 | 0 | 2 | $-164 075 |
| Jeffrey S. Flier | Consejero | 1 de julio de 2026 S | 27 856 | 0 | 3 | $-164 491 |
| Kristina Burow | Consejero | 1 de julio de 2026 S | 114 657 | 0 | 2 | $-164 053 |
| Michael Gilman | Consejero | 1 de julio de 2026 S | 59 511 | 0 | 3 | $-137 058 |
| Richard Brudnick | Consejero | 4 de junio de 2026 A | 21 896 | 0 | 0 | $0 |
| Srinivas Akkaraju | Consejero | 4 de junio de 2026 A | 27 971 | 9 | 0 | $19 988 986 |
| Amir Nashat | Consejero | 9 de mayo de 2024 J | 38 639 | 0 | 0 | $0 |
| Timothy A. Springer | Propietario del 10% | 10 de diciembre de 2019 G | 2 376 567 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 35 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| IBRN · iShares Trust | 4,94% | 6 638 SH | 11 de septiembre de 2026 | Diario |
| GURU · Global X Funds | 1,09% | 14 083 NS | 31 de julio de 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,73% | 76 534 NS | 31 de julio de 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,72% | 7 035 NS | 31 de julio de 2026 | N-PORT |
| IBB · iShares Trust | 0,40% | 737 768 SH | 11 de septiembre de 2026 | Diario |
| IWO · iShares Trust | 0,38% | 988 363 SH | 11 de septiembre de 2026 | Diario |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,38% | 8 611 SH | 2 de octubre de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,34% | 112 682 SH | 19 de agosto de 2026 | Diario |
| ESSC · Strategy Shares | 0,23% | 1 785 NS | 31 de julio de 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,21% | 1 046 NS | 31 de julio de 2026 | N-PORT |
| IWM · iShares Trust | 0,20% | 2 857 880 SH | 11 de septiembre de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,19% | 643 358 SH | 19 de agosto de 2026 | Diario |
| BKSE · BNY Mellon ETF Trust | 0,17% | 3 180 NS | 31 de julio de 2026 | N-PORT |
| RSSL · Global X Funds | 0,17% | 53 534 NS | 31 de julio de 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,16% | 23 797 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,06% | 1 141 089 SH | 19 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,06% | 224 721 SH | 19 de agosto de 2026 | Diario |
| ESML · iShares Trust | 0,06% | 29 351 SH | 11 de septiembre de 2026 | Diario |
| FBCG · FIDELITY COVINGTON TRUST | 0,05% | 79 589 NS | 31 de julio de 2026 | N-PORT |
| ISCG · iShares Trust | 0,05% | 9 027 SH | 11 de septiembre de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,05% | 35 479 NS | 31 de julio de 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,05% | 26 694 SH | 2 de octubre de 2026 | Diario |
| WSML · iShares Trust | 0,04% | 5 311 SH | 11 de septiembre de 2026 | Diario |
| VFMO · VANGUARD WELLINGTON FUND | 0,02% | 7 030 SH | 19 de agosto de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 5 664 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 3 428 276 SH | 19 de agosto de 2026 | Diario |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 89 618 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 9 206 SH | 19 de agosto de 2026 | Diario |
| ESGV · VANGUARD WORLD FUND | 0,01% | 24 696 SH | 19 de agosto de 2026 | Diario |
| IWV · iShares Trust | 0,01% | 29 962 SH | 11 de septiembre de 2026 | Diario |
| ITOT · iShares Trust | 0,01% | 134 626 SH | 11 de septiembre de 2026 | Diario |
| TILT · FlexShares Trust | 0,01% | 3 402 NS | 31 de julio de 2026 | N-PORT |
| IWN · iShares Trust | · | 62 011 SH | 11 de septiembre de 2026 | Diario |
| ISCB · iShares Trust | · | 3 926 SH | 11 de septiembre de 2026 | Diario |
| ISCV · iShares Trust | · | 13 116 SH | 11 de septiembre de 2026 | Diario |
SRRK Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 24 analistas
COMPRA
Objetivo mediano
$71.50
+52,7%
9 37,5%
Compra fuerte
14 58,3%
Compra
1 4,2%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
16 analistas · 2026-09-29Objetivo medio $70.44 +50,5%
← Por Debajo de Todos los Objetivos
Precio Actual $46.81
Mín$58.00
Media$70.44
Máx$84.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| SRRK | $4.78B | -13.4 | · | · | -157.9% | · |
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | · |
| GRAL | $3.45B | -7.7 | 17.2% | -277.5% | -16.7% | · |
| RYTM | $7.19B | -34.4 | 45.8% | -103.6% | -309.1% | · |
| CGON | $3.35B | -20.0 | 254.7% | -3985.0% | -22.6% | · |
| KOD | $1.73B | -6.5 | · | · | -202.0% | · |
| ORKA | $1.48B | -3.3 | · | · | -25.9% | · |
| MIRM | $4.10B | -168.1 | 54.7% | -4.5% | -8.2% | · |
| COGT | $5.72B | -16.4 | · | · | -83.1% | · |
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | · |
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 6, 2026